These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8380141)

  • 1. Characterization of insulin-like growth factor II receptors in human small cell lung cancer cell lines.
    Schardt C; Rotsch M; Erbil C; Göke R; Richter G; Havemann K
    Exp Cell Res; 1993 Jan; 204(1):22-9. PubMed ID: 8380141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
    Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
    J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
    J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
    Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
    Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.
    de Cupis A; Ciomei M; Pirani P; Ferrera A; Ardizzoni A; Favoni RE
    Br J Pharmacol; 1997 Feb; 120(3):537-43. PubMed ID: 9031761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of insulin-like growth factor receptors in human thyroid tissue.
    Cissewski K; Wolf M; Moses AC
    Receptor; 1992; 2(3):145-53. PubMed ID: 1472949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracellular transport of insulin-like growth factor-I (IGF-I) across human umbilical vein endothelial cell monolayers.
    Bastian SE; Walton PE; Belford DA
    J Cell Physiol; 1997 Mar; 170(3):290-8. PubMed ID: 9066786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro.
    Ankrapp DP; Bevan DR
    Cancer Res; 1993 Jul; 53(14):3399-404. PubMed ID: 8391925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
    Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
    J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
    Osipo C; Dorman S; Frankfater A
    Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
    Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A).
    Giannini S; Maggi M; Cresci B; Finetti G; Bonaccorsi L; Luconi M; Rotella CM; Forti G; Serio M; Baldi E
    Gynecol Oncol; 1996 Jun; 61(3):333-40. PubMed ID: 8641611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.